News | Cardiovascular Business | July 08, 2020

Philips and Leeds Teaching Hospitals NHS Trust Partner on New Standards For Integrated Cardiac Care

Seven-year agreement puts patients at heart of service design to support increased excellence across specialist care, research and local care provision

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.


July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agreement to deliver on the Trusts’ vision to set new standards of excellence for cardiac care in the U.K. and globally. The partnership will combine the latest innovations in technology for integrated cardiovascular solutions. The aim of the partnership is better health outcomes, lower cost of care and an improved experience for patients and staff. The service improvement program will support the co-design of new patient pathways and workflows, all with the aim of delivering the best care experience for patients.

Leeds Hospital in the U.K. is partnering with Philips healthcare“The cardiology team at Leeds Teaching Hospitals are very proud of the quality of cardiac care we are able to deliver for our patients,” said Dr. Chris Pepper, clinical director for cardiology at Leeds Teaching Hospitals NHS Trust. “We see this partnership as a hugely exciting and positive opportunity to improve this further. We look forward to being able to provide state-of-the-art cardiac imaging as part of a highly efficient and forward-looking cardiology service for the people of Leeds and West Yorkshire. We also look forward to a positive and collaborative working relationship with Philips.”

The agreement includes six fully featured interventional cardiac suites based on the Philips Azurion platform, including two specialized electrophysiology suites and a structural heart suite, as well as advanced patient monitoring and ultrasound systems. The Azurion platform provides an intuitive, seamless approach for minimally invasive procedures that will support Leeds’ clinicians to focus on treating the patient, and its administrators as they strive to improve productivity and efficiency through intelligent resource management.

“We are now working through the backlog of patients and other challenges created by the COVID-19 pandemic," Pepper continued. "We need to keep services running and have been supported through our partnership with Philips including in reorganizing lab allocations and maintaining patient flow, which has been of substantial benefit. Our cath labs are an essential part of our operations, so when two of our systems recently needed urgent repair, we were happy that Philips was able to resolve the issues without impact on our daily workflow. Our state-of-the-art ultrasound systems have also helped us maintain efficiency after the first wave of COVID-19 patients and will help streamline and facilitate further recovery.”

"Cardiovascular disease is one of the world’s leading causes of death[1] and in the U.K. we are now seeing more people dying of heart disease at younger ages than in previous years,” said Neil Mesher, general manager of Philips U.K. and Ireland. “The COVID-19 pandemic has shown what we can achieve when we combine our collective resources to combat an urgent, complex challenge. It’s with this spirit that we look forward to working side-by-side with Leeds Teaching Hospitals NHS Trust to improve the region’s cardiac health.”

Leeds Cardiac Clinical Services Unit sees over 25,000 patients a year and offers specialist cardiology services to a regional U.K. population of over 5.4 million across West Yorkshire. As both a local care provider and international specialism centre, the Trust operates an aspirational international innovation program that not only benefits the local population but also the global cardiology community by developing cutting-edge techniques to meet challenging patient presentations. With both local and international objectives, Leeds has decided to work in partnership with Philips on a long-term basis to ensure these aspirations are met.

Reference:

1. U.K. health data visualised: Death rates - over time. British heart Foundation. https://www.bhf.org.uk/what-we-do/our-research/heart-and-circulatory-diseases-in-numbers/death-rates-over-time

 

Related Content

News | Angiography

April 7, 2021 — Philips Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Philips ...

Home April 07, 2021
Home
Feature | Angiography | By Bhvita Jani

January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve ...

Home January 19, 2021
Home
News | Angiography

December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided ...

Home December 01, 2020
Home
Feature | Angiography | Dave Fornell, Editor

Philips is working on a prototype cath lab angiographic imaging system that might be able to replace the current X-ray ...

Home March 12, 2020
Home
News | Angiography

February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the ...

Home February 12, 2020
Home
News | Angiography

October 9, 2019 — In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date ...

Home October 09, 2019
Home
Technology | Angiography

September 17, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of ...

Home September 17, 2019
Home
News | Angiography

August 21, 2019 — Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac ...

Home August 21, 2019
Home
Technology | Angiography

June 24, 2019 — Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST ...

Home June 24, 2019
Home
Technology | Angiography

June 4, 2019 — Medis Medical Imaging Systems B.V. has received clearance from the U.S. Food and Drug Administration for ...

Home June 04, 2019
Home
Subscribe Now